Habib J. Dable, CEO and President at ACCELERON PHARMA INC (XLRN), sold 24,650 shares at $53.65 ($1.3M) on 2018-12-04, disclosed to the SEC on 2018-12-06.
Open-market sale of $1.3M XLRN by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.54 | 2,506 | $129K | 9.9% |
| 2 | $51.54 | 2,506 | $129K | 9.9% |
| 3 | $52.72 | 3,862 | $204K | 15.6% |
| 4 | $52.72 | 3,862 | $204K | 15.6% |
| 5 | $53.65 | 5,607 | $301K | 23.0% |
| 6 | $53.65 | 5,607 |
| $301K |
| 23.0% |
| 7 | $54.33 | 700 | $38K | 2.9% |
| Total | $52.95 avg | 24,650 | $1.3M | 100% |
| Filing → |
| XLRN | SELL | 2020-07-06 | $8.9M | — | Filing → |
| XLRN | SELL | 2020-01-03 | $377K | — | Filing → |
| XLRN | SELL | 2019-09-10 | $493K | — | Filing → |